Back

The ppargamma agonist pioglitazone reverses pulmonary arterial hypertension (PAH) and prevents right heart failure through fatty acid oxidation (fao)

20 April 2018 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: All day Poster Session - Basic Science - Cardiac Diseases Heart Failure Open Access Frontiers in CardioVascular Biology 2018 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Ekaterina Legchenko

Hannover Medical School, Hannover (Germany)

51 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Presentation thumbnail
Miss V. Stankovikj (Manchester, GB)
Abstract
Presentation thumbnail
Mr J. Eding (Utrecht, NL)
Abstract
Presentation thumbnail
Associate Professor A. Kiss (Vienna, AT)
Abstract

Access the full session

Session thumbnail
All day Poster Session - Basic Science - Cardiac Diseases

The Event

Event poster

Frontiers in CardioVascular Biology 2018

20 April 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Metabolic syndrome contributes to the pulmonary arterial dysfunction in pulmonary hypertension in heart failure with preserved ejection fraction
31 August 2020
thumbnail
Congress Presentation
Interleukin-22 inhibits right ventricular remodelling by a unique mechanism in a pulmonary artery constriction model.
30 August 2024
thumbnail
Congress Presentation
Nuclear receptor PPAR alpha, transcriptional coactivator PGC-1 alpha and cardiac metabolic remodeling in heart failure
29 June 2021
thumbnail
Congress Presentation
Unveiling the true burden of hospitalizations in pulmonary arterial hypertension: a comprehensive follow-up analysis
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources